Orion Biotech Opportunities Statistics Share Statistics Orion Biotech Opportunities has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 200, so 0% of the outstanding
shares have been sold short.
Short Interest 200 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.74
Valuation Ratios The PE ratio is 10.92 and the forward
PE ratio is null.
Orion Biotech Opportunities's PEG ratio is
0.
PE Ratio 10.92 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.03 P/FCF Ratio -533.5 PEG Ratio 0
Financial Ratio History Enterprise Valuation Orion Biotech Opportunities has an Enterprise Value (EV) of 200.73M.
EV / Sales 0 EV / EBITDA -19.02 EV / EBIT -532.8 EV / FCF -532.8
Financial Position The company has a current ratio of 6.5,
with a Debt / Equity ratio of 0.
Current Ratio 6.5 Quick Ratio 6.5 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 9.44% and Return on Invested Capital is -0.93%.
Return on Equity 9.44% Return on Assets 9.06% Return on Invested Capital -0.93% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -9.66M Effective Tax Rate -110.28%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Orion Biotech Opportunities's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 9.85 200-Day Moving Average 9.92 Relative Strength Index (RSI) 12.72 Average Volume (20 Days) 201
Income Statement
Revenue n/a Gross Profit n/a Operating Income -900K Net Income 18.41M EBITDA -10.56M EBIT -10.56M Earnings Per Share (EPS) 0.92
Full Income Statement Balance Sheet The company has 265.72K in cash and 0 in
debt, giving a net cash position of 265.72K.
Cash & Cash Equivalents 265.72K Total Debt n/a Net Cash n/a Retained Earnings -7.79M Total Assets 203.33M Working Capital 371.73K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -376.76K
and capital expenditures 0, giving a free cash flow of -376.76K.
Operating Cash Flow -376.76K Capital Expenditures n/a Free Cash Flow -376.76K FCF Per Share -0.02
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
